Access! 2023 Presentations

FDA Keynote Address
Jacqueline Corrigan-Curay, JD, M.D.
, Principal Deputy Center Director, Center for Drug Evaluation and Research, FDA
Download Presentation Here

U.S. Generics and Biosimilars: Trends, Issues and Outlook
Doug Long
, Vice President, Industry Relations, IQVIA
Download Presentation Here

Growth and Uncertainty for the Biosimilars Market
Michael Kleinrock
, Research Director, The IQVIA Institute
Download the Institute Report: Biosimilars in the United States 2023-2027

Brand Reputation Keynote Address
Martin Lindstrom
, Founder and Chairman, Lindstrom Company
Kelley Dougherty, Vice President, North America Brand & Communications, Teva Pharmaceuticals
Erica Klinger, Senior Director of Marketing, AAM
Maryll Toufanian, JD, Senior Vice President, Regulatory Strategy and Policy, Amneal Pharmaceuticals
Download Presentation Here

Access! 2023 + IGBA Partnership Luncheon
Dan Milner, MD, MSc, MBA
, Executive Director, Access to Oncology Medicines (ATOM) Coalition
Download Presentation Here

Recent News

Generics

are a proven prescription for a healthier society.

Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.

AAM Tweets